Legal & General Group
BHVN

Legal & General Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Legal & General Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-86,684
Closed -$13.1M – 3488
2022
Q3 		$13.1M Sell
86,684
-649
-0.7% -$96.2K 0.01% 926
2022
Q2 		$12.7M Buy
87,333
+32,299
+59% +$4.13M ﹤0.01% 960
2022
Q1 		$6.53M Buy
55,034
+2,721
+5% +$339K ﹤0.01% 1377
2021
Q4 		$7.21M Buy
52,313
+3,415
+7% +$434K ﹤0.01% 1386
2021
Q3 		$6.79M Buy
48,898
+12,031
+33% +$1.5M ﹤0.01% 1380
2021
Q2 		$3.58M Buy
36,867
+3,092
+9% +$251K ﹤0.01% 1712
2021
Q1 		$2.31M Buy
33,775
+222
+0.7% +$18K ﹤0.01% 1919
2020
Q4 		$2.88M Sell
33,553
-128
-0.4% -$10.8K ﹤0.01% 1740
2020
Q3 		$2.19M Buy
33,681
+3,122
+10% +$205K ﹤0.01% 1728
2020
Q2 		$2.23M Buy
30,559
+3,700
+14% +$197K ﹤0.01% 1685
2020
Q1 		$914K Sell
26,859
-4,578
-15% -$209K ﹤0.01% 1873
2019
Q4 		$1.71M Buy
31,437
+922
+3% +$45.7K ﹤0.01% 1871
2019
Q3 		$1.27M Buy
30,515
+14,559
+91% +$615K ﹤0.01% 1898
2019
Q2 		$698K Buy
15,956
+937
+6% +$52.8K ﹤0.01% 2071
2019
Q1 		$773K Buy
15,019
+9,735
+184% +$421K ﹤0.01% 2049
2018
Q4 		$196K Buy
5,284
+652
+14% +$23.5K ﹤0.01% 2307
2018
Q3 		$174K Buy
4,632
+215
+5% +$7.91K ﹤0.01% 2367
2018
Q2 		$175K Sell
4,417
-1,209
-21% -$38.4K ﹤0.01% 2330
2018
Q1 		$145K Buy
5,626
+2,963
+111% +$88.6K ﹤0.01% 2377
2017
Q4 		$72K Sell
2,663
-484
-15% -$13.3K ﹤0.01% 2737
2017
Q3 		$119K Buy
3,147
+379
+14% +$11.5K ﹤0.01% 2555
2017
Q2 		$69K Buy
+2,768
New +$63.7K ﹤0.01% 2803

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Legal & General Group's BHVN Position: Q4 2022 in Review

Legal & General Group sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 86,684 shares — an estimated $13.1M sold.

Legal & General Group first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $13.1M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Legal & General Group reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Legal & General Group sold 86,684 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $13.1M.
  • Legal & General Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • Legal & General Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $13.1M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Legal & General Group's 13F filing for Q4 2022, filed 14 Feb 2023.